# US 2010/0168408 A1 · Compositions and methods for labeling of nucleic acid molecules

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168408 A1
- Document ID: US20100168408A1
- Status: Published application
- Kind: A1
- Application number: 12/649,662
- Filed: 2009-12-30
- Published: 2010-07-01
- Earliest claimed: 1999-05-21
- Assignees: Life Technologies Corporation
- Inventors: Christian E. Gruber; Po-Jen Shih
- Web page: https://patentgrep.com/patent/US20100168408A1

## CPC

- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12Q 1/68: involving nucleic acids
- C12Q 1/6813: Hybridisation assays
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/6862: Ligase chain reaction [LCR]
- G01N 27/44726: {using specific dyes, markers or binding molecules}
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention is generally related to compositions, kits and methods for labeling nucleic acid molecules using reverse transcriptases, preferably multi-subunit reverse transcriptases such as ASLV reverse transcriptases. Specifically, the invention relates to methods, kits and compositions for to fluorescently labeling nucleic acid molecules during nucleic acid synthesis. The labeled nucleic acid molecules produced in accordance with the invention are particularly suited as labeled probes for nucleic acid detection and diagnostics.

## Claims

### Claim 1

A composition for use in labeling one or more nucleic acid molecules, said composition comprising one or more enzymes having reverse transcriptase activity, wherein said enzymes are multi-subunit enzymes.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said enzymes are heterodimers.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said enzymes are selected from the group consisting of ASLV reverse transcriptases.

### Claim 4 (depends on 1)

The composition of claim 1, wherein said enzymes are reduced or substantially reduced in RNase H activity.

### Claim 5 (depends on 1)

The composition of claim 1, wherein said enzymes are selected from the group consisting of RSV reverse transcriptase, AMV reverse transcriptase, RAV reverse transcriptase, MAV reverse transcriptase and HIV reverse transcriptase, and derivatives, variants, fragments or mutants thereof.

### Claim 6 (depends on 1)

The composition of claim 1, wherein said composition further comprises one or more fluorescently labeled nucleotides.

### Claim 7 (depends on 6)

The composition of claim 6, wherein said nucleotides are labeled with a fluorescent molecule or marker selected from the group consisting of rhodamine, fluoroescein, Cy3, and Cy5.

### Claim 8 (depends on 1)

The composition of claim 1, wherein said composition further comprises one or more DNA polymerases, and mutants, fragments, variants and derivatives thereof.

### Claim 9 (depends on 1)

The composition of claim 1, wherein said composition further comprises a reverse transcription buffer and/or a nucleic acid template.

### Claim 10

A method for reverse transcription of one or more nucleic acid molecules comprising
(a) mixing one or more nucleic acid templates with one or more enzymes having reverse transcriptase activity, wherein said enzymes are multi-subunit enzymes; and
(b) incubating said mixture under conditions sufficient to make one or more first nucleic acid molecules complementary to all or a portion of said one or more templates, wherein at least one of said first nucleic acid molecules is detectably labeled.

### Claim 11 (depends on 10)

The method of claim 10, wherein said nucleic acid template is a messenger RNA (mRNA) molecule or a population of mRNA molecules.

### Claim 12 (depends on 10)

The method of claim 10, said method further comprising incubating said one or more first nucleic acid molecules under conditions sufficient to make one or more second nucleic acid molecules complementary to all or a portion of said one or more first nucleic acid molecules.

### Claim 13 (depends on 10)

The method of claim 10, wherein said enzymes are selected from the group consisting of ASLV reverse transcriptases.

### Claim 14 (depends on 10)

The method of claim 10, wherein said enzymes are selected from the group consisting of RSV RT, AMV RT, ThermoScript™ and ThermoScript™ II.

### Claim 15 (depends on 10)

The method of claim 10, wherein said detectable label is a fluorescent label.

### Claim 16 (depends on 10)

The method of claim 10, wherein said fluorescent label is selected from the group consisting of fluorescein, rhodamine, Cy3 and Cy5.

### Claim 17 (depends on 10)

The method of claim 10, wherein said detectably labeled first nucleic acid molecules comprise one or more fluorescently labeled nucleotides.

### Claim 18 (depends on 10)

The method of claim 10, wherein said detectable labels are the same or different.

### Claim 19 (depends on 18)

The method of claim 18, wherein said detectable labels are fluorescent labels.

### Claim 20 (depends on 10)

A labeled nucleic acid molecules prepared according to the method of claim 10.

### Claim 21

A kit for use in labeling one or more nucleic acid molecules, said kit comprising one or more enzymes having reverse transcriptase activity, wherein said enzymes are multi-subunit enzymes.

### Claim 22 (depends on 21)

The kit of claim 21, said kit further comprising one or more components selected from the group consisting of one or more nucleotides, one or more DNA polymerases, a suitable buffer, and one or more primers.

### Claim 23 (depends on 22)

The kit of claim 22, wherein at least one or said nucleotides are fluorescent nucleotides.
